For insights on best practices for compliance risk assessments, join BJ D’Avella, group leader of Paul Hastings Life Sciences Consulting Group, at the Pharmaceutical Compliance Forum Compliance 201 virtual workshop taking place June 20^th.

BJ will be joined by Lauren Hickson, director of risk, analytics and operational excellence at AbbVie, and Stephen Rhoades, global ethics and compliance at GlaxoSmithKline, on the session titled “Demystifying the Compliance Risk Assessment”.